Multivirus-Specific T Cell Immunotherapy to Prevent or Treat Infections of Stem Cell Transplant Recipients
Year: 2009
Type: article
Abstract: Viral infections cause morbidity and mortality in allogeneic HSCT recipients. To treat the underlying problem, namely lack of antigen-specific T cells, we and others have successfully generated and infused adoptive T-cell lines specific for EBV, CMV and Adenovirus. We have shown that as few as 2 × 105/kg trivirus-specific cytotoxic T lymphocytes (CTL) proliferated by several logs post-infusion and appeared to protect the recipients against all three viruses. Despite the encouraging clinical results, broader implementation of the approach is limited by (i) the usage of infectious virus material (EBV/Adv) and (ii) the prolonged culture (3 months for EBV-LCL production and CTL stimulation).
Authors: U. Gerdemann, A. Christin, Y. Fujita, J.F. Vera, C.A. Ramos, D. Dilloo, M.K. Brenner, H.E. Heslop, C.M. Rooney, A.M. Leen
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2117635801